Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
DEUTERATED HPK1 KINASE INHIBITOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2022/089225
Kind Code:
A1
Abstract:
Provided in the present invention are a compound of general formula I or a pharmaceutically acceptable salt, a stereoisomer, an ester, a prodrug and a solvate thereof, a preparation method therefor and the use thereof, and in particular, the use of the compound of general formula I or the pharmaceutically acceptable salt, the stereoisomer, the ester, the prodrug and the solvate thereof as an HPK1 kinase inhibitor in the prevention and/or treatment of tumors and diseases caused by or associated with pathogen infection. The above-mentioned compound of general formula I contains at least one deuterium atom, and has high stability and good bioavailability in an animal body.

Inventors:
LIN XINGYU (CN)
LU TINGTING (CN)
Application Number:
PCT/CN2021/124144
Publication Date:
May 05, 2022
Filing Date:
October 15, 2021
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
ZHUHAI YUFAN BIOTECHNOLOGIES CO LTD (CN)
International Classes:
C07D417/14; A61K31/4427; A61K31/4433; A61K31/444; A61K31/4523; A61K31/4545; A61K31/496; A61K31/497; A61K31/551; A61P35/00; A61P35/02; C07D401/14; C07D405/14; C07D417/04
Domestic Patent References:
WO2006021884A22006-03-02
Foreign References:
CN110396087A2019-11-01
CN1777427A2006-05-24
US20160158360A12016-06-09
CN110396087A2019-11-01
Other References:
S SAWASDIKOSOL: "HPK1 as a novel target for cancer immunotherapy", IMMUNOL RES,, vol. 54, 2012, pages 262 - 265, XP035126315, DOI: 10.1007/s12026-012-8319-1
WADA, E, SEIKAGAKU, vol. 66, 1994, pages 15
GANNES, LZ, COMP BIOCHEM PHYSIOL MOL INTEGR PHYSIOL, vol. 119, 1998, pages 725
See also references of EP 4223752A4
Attorney, Agent or Firm:
BEIJING LINKTEC IP LAW FIRM (SPECIAL GENERAL PARTNERSHIP) (CN)
Download PDF: